US Stock MarketDetailed Quotes
GRCE Grace Therapeutics
- 3.700
- +0.100+2.78%
Close Dec 26 16:00 ET
- 3.610
- -0.090-2.44%
Pre 08:01 ET
37.52MMarket Cap-4.07P/E (TTM)
3.848High3.500Low32.05KVolume3.640Open3.600Pre Close116.75KTurnover0.69%Turnover RatioLossP/E (Static)10.14MShares4.96552wk High0.67P/B17.19MFloat Cap1.98052wk Low--Dividend TTM4.65MShs Float2016.000Historical High--Div YieldTTM9.67%Amplitude1.720Historical Low3.642Avg Price1Lot Size
Grace Therapeutics Key Stats
EPS
According to the latest financial report of Grace Therapeutics, the latest earnings per share (TTM) for the company is -0.30. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: USD
Quarterly
Loading...
FCF
Interested in knowing about Grace Therapeutics's free cash flow? The latest report shows it as -4.24M. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.
Currency: USD
Quarterly
Loading...
Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Grace Therapeutics shows that the company's current ratio is 6.01, indicating healthy liquidity.
Currency: USD
Quarterly
Loading...
Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Grace Therapeutics, the quick ratio is 5.83, indicating that the company can meet its short-term debt obligations.
Currency: USD
Quarterly
Loading...
ROE
Want to learn more about the financial health of Grace Therapeutics? The latest ROE figure is -5.94%, indicating that the company has stable profitability.
Currency: USD
Quarterly
Loading...
ROA
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Grace Therapeutics, the total asset return on investment (ROA) is -5.08%.
Currency: USD
Quarterly
Loading...
Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check Grace Therapeutics's latest financial report to see how their gross margin is doing - currently at 65.22%.
Currency: USD
Quarterly
Loading...
Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Grace Therapeutics, the net profit margin is -4.91K%, which is a good sign for its profitability.
Currency: USD
Quarterly
Loading...
Heat List
US
Overall
Symbol
Price
% Chg
No Data